source
- Dr Randall on the Rationale for Investigating CSF-1R Inhibition in TGCTR. Lor Randall, MD, FACS discusses safety and efficacy data from the MANEUVER trial, which evaluated pimicotinib in TGCT.onclive · 2mo ago↗ source
- Renal Cell Carcinoma: Real-World Factors in First-Line Treatment SelectionIn this segment, Dr. Elizabeth Plimack and Dr. Yasser Ged discuss how real-world patient factors influence first-line treatment decisions in renal cell carcinoma.onclive · 2mo ago↗ source
- Expanding ctDNA Applications to RCC and Germ Cell TumorsExperts explain how ctDNA tracking in metastatic cancer guides therapy tweaks, flags relapse early, and where it fails in brain/peritoneal disease.onclive · 2mo ago↗ source